Simon Fraser University
Engaging the World

The Healthy Cities Implementation Science (HCIS) Team Grants funding opportunity is offering grants focused on increasing our understanding of how to design, implement and promote the systematic and equitable uptake of evidence-based interventions (i.e. interventions that have been piloted or tested in a setting and found to be promising) in multiple urban environments to improve population health and well-being.

The Team Grants in Diabetes Prevention and Treatment in Indigenous Communities: Resilience and Wellness will support Indigenous-led and community-driven research that aims to reverse the upward trajectory of diabetes and associated co-morbidities (e.g. cardiometabolic disease) among First Nations, Inuit and Métis Peoples and their communities. The objective of this component is to define and integrate models of resilience and wellness into diabetes prevention and treatment approaches among First Nations, Inuit and Métis Peoples.

The 2021 Federal Budget announced funding for CIHR's Clinical Trials Fund (CTF), an integral component of Canada's Biomanufacturing and Life Sciences Strategy (BLSS). In support of this, the CTF will provide funding through three specific vehicles: platforms with the development of a pan-Canadian Clinical Trials Consortium; people with the funding of training platforms; and, projects through the funding of a broad spectrum of clinical trial initiatives. The CTF will support research and researchers across the country to conduct the full spectrum of clinical trials including the development and testing of new drugs, treatments, and public health and health system interventions to prevent, detect, treat, or manage various diseases or medical conditions.

Honours excellence in health research and its translation into benefits for Canadians.

This funding opportunity is part of Government of Canada's continued rapid response to address the health challenges of the COVID-19 pandemic. This funding will enable rapid and timely research responding to the current and next phase of the wider impacts of the COVID-19 pandemic in Canada and around the globe.

Recognizes exceptional contributions in the area of population and public health research.

Within its objective under the Canadian Institutes of Health Research Act, CIHR is charged with addressing emerging health challenges. CIHR is also positioned, as Canada's federal funding agency for health research, to provide focused public funding for emerging health challenges. Against this backdrop, and recognizing a need for independent research on cannabis health issues, CIHR is launching a funding opportunity for research projects. This current funding opportunity is comprised of two components: Existing Longitudinal Studies and a New Longitudinal Study on Cannabis Use in Veterans.

The goal of the Transitions in Care (TiC) CIHR multi-Institute initiative is to improve the health and well-being of all peoples in Canada by supporting research that transforms the health system to optimize the outcomes of patients experiencing transitions in care. Since the launch of the initiative in 2018, 53 projects have been funded across Canada using a number of different funding mechanisms. The focus of this funding opportunity is to support inter-disciplinary teams that are poised and ready to optimize health outcomes during transitions in care. The grants will provide support to co-develop, implement, evaluate, and equitably spread and/or scale (share) pragmatic solutions to challenges associated with transitions in care from a clinical, health care or health system perspective.

Recognizes an outstanding contribution to health services and policy research, policy and/or care delivery in Canada.

The Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects of research proposed and conducted by individual researchers or groups of researchers in all areas of health. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches.

The goal of the CIHR-ICRH/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma is to enable Canadian allergists, clinical immunologists, MD clinician scientists, and basic scientists working in translational research to pursue academic research in allergic asthma.

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

This program supports outstanding new investigators as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration and mentorship with established TFRI or CIHR-ICR-funded research teams

This funding opportunity supports the development and testing of innovative methodologies/designs of innovative clinical trials (iCT) that is integrated with the principles of Strategy for Patient-Oriented Research (SPOR).

This catalyst grant supports research to expand current evidence and understanding of disease prevention that will lead to future intervention studies.